Go Pro

Lam Research (LRCX) Financials

Lam Research logo
$343.84 +11.48 (+3.45%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$327.90 -15.94 (-4.64%)
As of 07:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Lam Research

Annual Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
Net Income / (Loss) Attributable to Common Shareholders
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Consolidated Net Income / (Loss)
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Net Income / (Loss) Continuing Operations
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Total Pre-Tax Income
960 1,812 3,152 2,447 2,575 4,371 5,193 5,109 4,360 5,958 8,262
Total Operating Income
1,074 1,902 3,213 2,465 2,674 4,482 5,382 5,175 4,264 5,901 8,200
Total Gross Profit
2,619 3,603 5,165 4,358 4,609 6,805 7,872 7,777 7,053 8,979 11,725
Total Revenue
5,886 8,014 11,077 9,654 10,045 14,626 17,227 17,429 14,905 18,436 23,233
Operating Revenue
5,886 8,014 11,077 9,654 10,045 14,626 17,227 17,429 14,905 18,436 23,233
Total Cost of Revenue
3,267 4,410 5,912 5,295 5,436 7,821 9,355 9,652 7,853 9,457 11,507
Operating Cost of Revenue
3,267 4,410 5,912 5,295 5,436 7,821 9,355 9,652 7,853 9,457 11,507
Total Operating Expenses
1,545 1,701 1,952 1,894 1,935 2,323 2,490 2,602 2,789 3,078 3,526
Selling, General & Admin Expense
631 667 762 702 682 830 886 833 868 982 1,150
Research & Development Expense
914 1,034 1,190 1,191 1,252 1,493 1,604 1,727 1,902 2,096 2,376
Restructuring Charge
- - - - - - - 42 18 0.00 0.00
Total Other Income / (Expense), net
-114 -90 -62 -18 -99 -111 -189 -66 96 57 63
Other Income / (Expense), net
-114 -90 -62 -18 -99 -111 -189 -66 96 57 63
Income Tax Expense
46 114 771 255 323 462 588 598 532 600 997
Basic Earnings per Share
$5.75 $10.47 $14.73 $14.37 $15.55 $27.22 $32.92 $3.33 $2.91 $4.17 $5.79
Weighted Average Basic Shares Outstanding
158.92M 162.22M 161.64M 152.48M 144.81M 143.61M 139.90M 1.35B 1.31B 1.29B 1.26B
Diluted Earnings per Share
$5.22 $9.24 $13.17 $13.70 $15.10 $26.90 $32.75 $3.32 $2.90 $4.15 $5.76
Weighted Average Diluted Shares Outstanding
175.16M 183.77M 180.78M 159.92M 149.09M 145.32M 140.63M 1.36B 1.32B 1.29B 1.26B
Weighted Average Basic & Diluted Shares Outstanding
159M 162.20M 161.60M 144.53M 145.63M 141.95M 136.99M 132.51M 129.88M 1.27B 1.25B

Quarterly Income Statements for Lam Research

This table shows Lam Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026
Net Income / (Loss) Attributable to Common Shareholders
954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277
Consolidated Net Income / (Loss)
954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277
Net Income / (Loss) Continuing Operations
954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277
Total Pre-Tax Income
1,087 1,093 1,154 1,294 1,348 1,537 1,779 1,859 1,837 2,012 2,555
Total Operating Income
1,057 1,057 1,127 1,264 1,334 1,562 1,741 1,829 1,810 2,047 2,513
Total Gross Profit
1,757 1,801 1,840 2,003 2,073 2,314 2,590 2,685 2,651 2,911 3,479
Total Revenue
3,758 3,794 3,872 4,168 4,376 4,720 5,171 5,324 5,345 5,841 6,722
Operating Revenue
3,758 3,794 3,872 4,168 4,376 4,720 5,171 5,324 5,345 5,841 6,722
Total Cost of Revenue
2,001 1,993 2,031 2,165 2,303 2,406 2,582 2,639 2,694 2,931 3,243
Operating Cost of Revenue
1,986 1,993 2,011 2,165 2,303 2,406 2,582 2,639 2,694 2,931 3,243
Total Operating Expenses
700 743 714 738 739 752 849 856 841 864 965
Selling, General & Admin Expense
229 216 216 243 244 226 268 279 268 280 322
Research & Development Expense
470 512 498 495 495 526 580 576 573 583 643
Total Other Income / (Expense), net
30 36 28 30 14 -25 38 30 26 -35 42
Other Income / (Expense), net
30 36 28 30 14 -25 38 30 26 -35 42
Income Tax Expense
133 127 134 178 157 206 59 291 243 186 278
Basic Earnings per Share
$0.72 $0.74 $7.81 $0.86 $0.93 $1.04 $1.34 $1.24 $1.27 $1.46 $1.81
Weighted Average Basic Shares Outstanding
1.32B 1.31B 131.41M 1.30B 1.29B 1.28B 1.29B 1.26B 1.25B 1.25B 1.26B
Diluted Earnings per Share
$0.72 $0.73 $7.78 $0.86 $0.92 $1.03 $1.34 $1.24 $1.26 $1.45 $1.81
Weighted Average Diluted Shares Outstanding
1.32B 1.32B 132.00M 1.30B 1.29B 1.29B 1.29B 1.27B 1.26B 1.26B 1.26B
Basic & Diluted Earnings per Share
- - - - - - $1.34 - - - $1.81
Weighted Average Basic & Diluted Shares Outstanding
131.10M 130.74M 129.88M 1.29B 1.28B 1.28B 1.27B 1.26B 1.25B 1.25B 1.25B
Cash Dividends to Common per Share
- - - - $0.23 $0.23 $0.23 - $0.26 $0.26 $0.26

Annual Cash Flow Statements for Lam Research

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
Net Change in Cash & Equivalents
3,811 -2,656 2,135 -855 1,256 -498 -897 1,814 263 557 -810
Net Cash From Operating Activities
1,295 2,029 2,656 3,176 2,126 3,588 3,100 5,179 4,652 6,173 5,858
Net Cash From Continuing Operating Activities
1,295 2,029 2,656 3,176 2,126 3,588 3,100 5,179 4,652 6,173 5,858
Net Income / (Loss) Continuing Operations
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Consolidated Net Income / (Loss)
914 1,698 2,381 2,191 2,252 3,908 4,605 4,511 3,828 5,358 7,265
Depreciation Expense
291 307 326 309 269 307 334 342 360 386 442
Non-Cash Adjustments To Reconcile Net Income
191 166 248 189 196 203 214 339 303 350 354
Changes in Operating Assets and Liabilities, net
-101 -167 -314 487 -590 -830 -2,054 -13 161 79 -2,203
Net Cash From Investing Activities
469 -2,053 2,749 -1,637 -244 73 612 -535 -371 -708 -922
Net Cash From Continuing Investing Activities
469 -2,053 2,749 -1,637 -244 73 612 -535 -371 -708 -922
Purchase of Property, Plant & Equipment
-175 -157 -273 -303 -203 -349 -546 -502 -397 -759 -966
Sale and/or Maturity of Investments
643 2,698 5,686 1,604 2,883 3,854 1,734 98 38 0.00 0.00
Other Investing Activities, net
1.64 -13 -15 -7.36 -26 -42 -7.58 -11 -12 51 44
Net Cash From Financing Activities
2,048 -2,632 -3,272 -2,390 -624 -4,167 -4,579 -2,831 -3,996 -4,937 -5,718
Net Cash From Continuing Financing Activities
2,048 -2,632 -3,272 -2,390 -624 -4,167 -4,579 -2,831 -3,996 -4,937 -5,718
Repayment of Debt
-0.49 -1,688 -1,506 -493 -1,916 -864 -12 -27 -270 -507 -769
Repurchase of Common Equity
-158 -812 -2,653 -3,781 -1,370 -2,698 -3,866 -2,017 -2,843 -3,422 -3,851
Payment of Dividends
-190 -243 -308 -678 -657 -727 -815 -908 -1,019 -1,150 -1,271
Issuance of Common Equity
59 73 85 85 94 122 114 121 136 143 173
Effect of Exchange Rate Changes
-0.72 -0.06 2.59 -4.04 -2.75 7.22 -30 0.13 -22 28 -27
Cash Interest Paid
- 105 84 77 172 204 176 175 173 172 150

Quarterly Cash Flow Statements for Lam Research

This table details how cash moves in and out of Lam Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026
Net Change in Cash & Equivalents
499 48 177 221 -395 -214 945 304 -516 -1,429 831
Net Cash From Operating Activities
1,454 1,385 862 1,568 742 1,309 2,554 1,779 1,480 1,141 1,457
Net Cash From Continuing Operating Activities
1,454 1,385 862 1,568 742 1,309 2,554 1,779 1,480 1,141 1,457
Net Income / (Loss) Continuing Operations
954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277
Consolidated Net Income / (Loss)
954 966 1,020 1,116 1,191 1,331 1,720 1,569 1,594 1,825 2,277
Depreciation Expense
91 90 88 94 96 97 98 102 104 116 120
Non-Cash Adjustments To Reconcile Net Income
74 87 75 80 73 89 109 95 69 94 96
Changes in Operating Assets and Liabilities, net
335 242 -321 278 -619 -208 627 13 -286 -894 -1,036
Net Cash From Investing Activities
-102 -92 -102 -111 -175 -293 -129 -186 -258 -335 -144
Net Cash From Continuing Investing Activities
-102 -92 -102 -111 -175 -293 -129 -186 -258 -335 -144
Purchase of Property, Plant & Equipment
-115 -104 -101 -111 -188 -288 -172 -185 -261 -332 -189
Other Investing Activities, net
-2.52 -3.36 -0.87 0.04 13 -4.86 43 -0.93 3.10 -2.98 45
Net Cash From Financing Activities
-860 -1,236 -574 -1,259 -935 -1,233 -1,510 -1,282 -1,725 -2,231 -480
Net Cash From Continuing Financing Activities
-860 -1,236 -574 -1,259 -935 -1,233 -1,510 -1,282 -1,725 -2,231 -480
Repayment of Debt
-4.81 -0.76 -8.82 -1.26 -0.27 -504 -2.31 -14 -2.58 -751 -1.64
Repurchase of Common Equity
-645 -981 -374 -997 -698 -435 -1,292 -976 -1,466 -1,163 -247
Payment of Dividends
-264 -263 -261 -261 -298 -296 -295 -292 -328 -326 -325
Issuance of Common Equity
55 8.24 70 -0.04 60 1.99 80 0.00 71 9.17 93
Effect of Exchange Rate Changes
6.73 -8.45 -9.62 23 -26 2.38 29 -7.06 -13 -4.98 -2.06

Annual Balance Sheets for Lam Research

This table presents Lam Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
Total Assets
12,264 12,123 12,479 12,001 14,559 15,892 17,196 18,782 18,745 21,345 23,530
Total Current Assets
9,213 9,142 9,150 8,560 10,854 11,652 12,285 13,228 12,883 14,517 15,611
Cash & Equivalents
5,039 2,378 4,512 3,658 4,915 4,418 3,522 5,337 5,848 6,391 5,579
Accounts Receivable
1,262 1,673 2,177 1,456 2,097 3,026 4,314 2,823 2,519 3,378 5,340
Inventories, net
972 1,233 1,876 1,540 1,900 2,689 3,966 4,816 4,218 4,308 4,276
Prepaid Expenses
151 195 147 134 146 208 347 252 298 440 416
Plant, Property, & Equipment, net
640 686 903 0.00 0.00 0.00 1,648 1,857 2,155 2,429 2,956
Total Noncurrent Assets
2,412 2,295 2,427 3,441 3,706 4,240 3,263 3,697 3,707 4,400 4,963
Goodwill
1,386 1,386 1,485 1,485 1,484 1,490 1,515 1,622 1,765 1,809 1,896
Other Noncurrent Operating Assets
210 242 368 1,484 1,799 2,365 1,394 1,906 1,942 2,591 3,067
Total Liabilities & Shareholders' Equity
12,264 12,123 12,479 12,001 14,559 15,892 17,196 18,782 18,745 21,345 23,530
Total Liabilities
6,162 5,135 5,899 7,278 9,376 9,865 10,917 10,571 10,205 11,484 11,059
Total Current Liabilities
2,418 2,950 3,150 2,372 3,162 3,528 4,565 4,185 4,338 6,568 5,937
Short-Term Debt
948 908 610 667 840 11 7.38 8.36 505 754 4.07
Accounts Payable
348 465 511 377 592 830 1,011 471 614 854 1,302
Accrued Expenses
773 969 1,309 947 1,273 1,719 1,974 2,011 1,802 2,394 2,352
Current Deferred Revenue
349 608 720 381 458 967 - 1,695 1,418 2,566 2,279
Total Noncurrent Liabilities
3,744 2,185 2,749 4,906 6,213 6,337 6,353 6,387 5,867 4,915 5,122
Long-Term Debt
3,378 1,785 1,807 3,823 4,971 4,990 4,998 5,003 4,479 3,730 3,730
Noncurrent Deferred Revenue
232 120 852 893 910 948 931 882 813 603 681
Other Noncurrent Operating Liabilities
135 280 91 191 333 399 423 501 575 582 710
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862 12,471
Total Preferred & Common Equity
5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862 12,471
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
5,895 6,817 6,502 4,674 5,172 6,027 6,278 8,210 8,539 9,862 12,471
Common Stock
5,573 5,846 6,145 6,410 6,696 7,053 7,415 7,809 8,224 8,699 9,246
Retained Earnings
4,820 6,250 8,261 9,931 11,521 14,685 18,455 22,032 24,811 28,989 34,950
Treasury Stock
-4,429 -5,216 -7,846 -11,603 -12,950 -15,647 -19,481 -21,530 -24,366 -27,763 -31,598
Accumulated Other Comprehensive Income / (Loss)
-69 -62 -57 -64 -94 -64 -110 -101 -130 -62 -127

Quarterly Balance Sheets for Lam Research

This table presents Lam Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/25/2023 9/24/2023 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 9/28/2025 12/28/2025 3/29/2026
Total Assets
18,782 18,538 18,784 18,280 18,745 19,532 19,840 19,968 21,900 21,391 20,792
Total Current Assets
13,228 12,994 13,055 12,488 12,883 13,492 13,613 13,460 14,807 14,018 13,297
Cash & Equivalents
5,337 5,126 5,623 5,672 5,848 6,067 5,665 5,451 6,693 6,180 4,751
Accounts Receivable
2,823 2,811 2,707 2,204 2,519 2,937 3,305 3,228 3,633 3,492 4,133
Inventories, net
4,816 4,748 4,430 4,323 4,218 4,210 4,358 4,463 4,095 4,038 4,000
Prepaid Expenses
252 278 279 290 298 278 284 318 386 308 413
Plant, Property, & Equipment, net
1,857 2,111 2,147 2,182 2,155 2,214 2,314 2,372 2,511 2,711 2,854
Total Noncurrent Assets
3,697 3,434 3,582 3,609 3,707 3,826 3,913 4,136 4,583 4,662 4,641
Goodwill
1,622 1,626 1,627 1,627 1,765 1,758 1,761 1,795 1,827 1,864 1,882
Other Noncurrent Operating Assets
1,906 1,650 1,804 1,840 1,942 2,068 2,152 2,341 2,756 2,798 2,759
Total Liabilities & Shareholders' Equity
18,782 18,538 18,784 18,280 18,745 19,532 19,840 19,968 21,900 21,391 20,792
Total Liabilities
10,571 10,491 10,561 10,258 10,205 11,061 11,032 10,457 11,707 11,246 10,207
Total Current Liabilities
4,185 4,247 4,272 4,430 4,338 5,343 5,350 5,490 6,708 6,213 5,242
Short-Term Debt
8.36 3.86 3.78 505 505 505 504 754 754 754 4.10
Accounts Payable
471 528 500 532 614 704 822 853 863 1,027 1,072
Accrued Expenses
2,011 2,120 1,976 1,792 1,802 2,196 2,096 2,000 2,444 2,267 2,075
Current Deferred Revenue
1,695 1,595 - 1,602 1,418 1,937 - 1,882 2,646 2,165 2,091
Total Noncurrent Liabilities
6,387 6,244 6,289 5,827 5,867 5,718 5,682 4,967 5,000 5,033 4,965
Long-Term Debt
5,003 4,980 4,980 4,478 4,479 4,479 4,478 3,730 3,730 3,730 3,730
Noncurrent Deferred Revenue
882 781 798 832 813 665 670 691 646 668 622
Other Noncurrent Operating Liabilities
501 483 511 517 575 574 534 547 624 635 613
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
8,210 8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585
Total Preferred & Common Equity
8,210 8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
8,210 8,047 8,222 8,022 8,539 8,472 8,808 9,511 10,193 10,145 10,585
Common Stock
7,809 7,879 7,997 8,082 8,224 8,304 8,441 8,530 8,796 8,950 9,055
Retained Earnings
22,032 22,655 23,347 24,052 24,811 25,630 26,525 27,561 30,230 31,498 32,998
Treasury Stock
-21,530 -22,366 -23,004 -23,985 -24,366 -25,375 -26,024 -26,456 -28,760 -30,204 -31,348
Accumulated Other Comprehensive Income / (Loss)
-101 -121 -118 -128 -130 -88 -134 -124 -74 -99 -121

Annual Metrics And Ratios for Lam Research

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/26/2016 6/25/2017 6/24/2018 6/30/2019 6/28/2020 6/27/2021 6/26/2022 6/25/2023 6/30/2024 6/29/2025 6/28/2026
DEI Shares Outstanding
- - - - - - - - - - 1,250,571,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,250,571,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 5.81
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.91% 36.15% 38.23% -12.85% 4.05% 45.61% 17.78% 1.17% -14.48% 23.68% 26.02%
EBITDA Growth
22.81% 71.35% 62.91% -21.09% 3.18% 64.51% 18.15% -1.36% -13.42% 34.42% 37.19%
EBIT Growth
29.60% 88.69% 73.97% -22.38% 5.25% 69.74% 18.81% -1.62% -14.66% 36.65% 38.68%
NOPAT Growth
46.66% 74.29% 36.16% -9.04% 5.91% 71.41% 19.08% -4.27% -18.07% 41.77% 35.87%
Net Income Growth
39.43% 85.74% 40.22% -7.95% 2.75% 73.57% 17.83% -2.05% -15.14% 39.98% 35.59%
EPS Growth
41.08% 77.01% 42.53% 4.02% 10.22% 78.15% 21.75% 1.40% -12.68% 43.10% 38.80%
Operating Cash Flow Growth
94.38% 56.70% 30.87% 19.59% -33.05% 68.74% -13.61% 67.08% -10.17% 32.69% -5.11%
Free Cash Flow Firm Growth
96.74% 54.53% 15.50% 22.37% -25.76% 62.99% -18.25% 66.02% -2.62% 27.15% -9.69%
Invested Capital Growth
-3.15% 1.01% 12.04% -6.96% 14.27% 25.24% 46.12% 6.91% -2.66% 3.66% 33.57%
Revenue Q/Q Growth
1.11% 11.07% 7.59% -7.34% 4.48% 10.20% 2.93% -7.57% 4.66% 7.59% 7.15%
EBITDA Q/Q Growth
10.23% 19.57% 11.34% -11.96% 5.35% 13.82% 1.09% -8.30% 6.53% 11.12% 10.08%
EBIT Q/Q Growth
13.11% 21.57% 12.68% -12.48% 5.70% 14.71% 0.98% -8.84% 7.14% 11.71% 10.37%
NOPAT Q/Q Growth
15.46% 15.83% 25.60% -17.56% 7.15% 12.52% 3.58% -10.21% 5.70% 14.93% 8.34%
Net Income Q/Q Growth
16.23% 18.70% 26.23% -17.95% 7.38% 12.95% 1.42% -8.26% 6.03% 15.02% 8.31%
EPS Q/Q Growth
16.00% 17.86% 27.37% -13.84% 8.71% 13.69% 2.50% -7.52% 6.38% 14.33% 7.26%
Operating Cash Flow Q/Q Growth
57.34% 30.34% -1.75% 5.38% -3.07% 21.01% -24.24% 15.08% -5.30% 37.75% -15.77%
Free Cash Flow Firm Q/Q Growth
24.23% 11.70% -1.43% 7.44% -4.37% 24.56% -26.52% 8.97% -1.19% 47.58% -19.40%
Invested Capital Q/Q Growth
-4.05% -2.33% 13.24% -5.32% 1.05% -1.98% 14.71% 1.18% 4.66% -6.90% 11.06%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
44.49% 44.97% 46.63% 45.15% 45.88% 46.53% 45.69% 44.62% 47.32% 48.71% 50.47%
EBITDA Margin
21.26% 26.75% 31.53% 28.55% 28.31% 31.98% 32.08% 31.28% 31.67% 34.41% 37.46%
Operating Margin
18.25% 23.74% 29.01% 25.53% 26.62% 30.64% 31.24% 29.69% 28.61% 32.01% 35.29%
EBIT Margin
16.31% 22.61% 28.45% 25.34% 25.64% 29.88% 30.15% 29.32% 29.25% 32.32% 35.56%
Profit (Net Income) Margin
15.53% 21.19% 21.49% 22.70% 22.42% 26.72% 26.73% 25.88% 25.68% 29.06% 31.27%
Tax Burden Percent
95.20% 93.71% 75.53% 89.57% 87.45% 89.42% 88.68% 88.29% 87.79% 89.93% 87.93%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
4.80% 6.29% 24.47% 10.43% 12.55% 10.58% 11.32% 11.71% 12.21% 10.07% 12.07%
Return on Invested Capital (ROIC)
30.04% 52.95% 67.66% 60.34% 61.88% 88.31% 76.84% 59.88% 48.11% 67.90% 77.61%
ROIC Less NNEP Spread (ROIC-NNEP)
34.73% 55.62% 69.12% 61.16% 69.24% 97.63% -210.15% 44.85% 33.91% 64.19% 74.67%
Return on Net Nonoperating Assets (RNNOA)
-14.07% -27.01% -32.57% -21.56% -16.42% -18.58% -1.99% 2.39% -2.41% -9.67% -12.54%
Return on Equity (ROE)
15.97% 25.94% 35.09% 38.77% 45.46% 69.73% 74.85% 62.27% 45.71% 58.24% 65.07%
Cash Return on Invested Capital (CROIC)
33.24% 51.95% 56.31% 67.55% 48.56% 65.89% 39.36% 53.20% 50.81% 64.31% 48.86%
Operating Return on Assets (OROA)
8.88% 14.86% 25.62% 19.99% 19.39% 28.71% 31.39% 28.40% 23.24% 29.72% 36.82%
Return on Assets (ROA)
8.45% 13.92% 19.35% 17.90% 16.96% 25.67% 27.84% 25.08% 20.40% 26.73% 32.38%
Return on Common Equity (ROCE)
15.34% 25.19% 34.45% 38.34% 45.18% 69.66% 74.85% 62.27% 45.71% 58.24% 65.07%
Return on Equity Simple (ROE_SIMPLE)
15.51% 24.90% 36.62% 46.89% 43.53% 64.85% 73.35% 54.94% 44.82% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,023 1,783 2,427 2,208 2,338 4,008 4,773 4,569 3,743 5,307 7,210
NOPAT Margin
17.38% 22.24% 21.91% 22.87% 23.28% 27.40% 27.70% 26.22% 25.11% 28.79% 31.04%
Net Nonoperating Expense Percent (NNEP)
-4.68% -2.67% -1.45% -0.82% -7.36% -9.32% 286.99% 15.03% 14.21% 3.71% 2.94%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 36.99% 44.49%
Cost of Revenue to Revenue
55.51% 55.03% 53.37% 54.85% 54.12% 53.47% 54.31% 55.38% 52.68% 51.30% 49.53%
SG&A Expenses to Revenue
10.72% 8.33% 6.88% 7.28% 6.79% 5.67% 5.14% 4.78% 5.83% 5.33% 4.95%
R&D to Revenue
15.52% 12.90% 10.74% 12.34% 12.47% 10.21% 9.31% 9.91% 12.76% 11.37% 10.23%
Operating Expenses to Revenue
26.24% 21.23% 17.62% 19.62% 19.26% 15.88% 14.45% 14.93% 18.71% 16.70% 15.17%
Earnings before Interest and Taxes (EBIT)
960 1,812 3,152 2,447 2,575 4,371 5,193 5,109 4,360 5,958 8,262
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,251 2,144 3,493 2,756 2,844 4,678 5,527 5,452 4,720 6,344 8,704
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.98 3.24 4.03 5.65 8.11 14.41 9.71 9.86 16.30 12.61 38.01
Price to Tangible Book Value (P/TBV)
2.96 4.39 5.57 8.88 11.92 19.71 13.08 12.62 20.55 15.44 44.83
Price to Revenue (P/Rev)
1.98 2.75 2.36 2.73 4.18 5.94 3.54 4.65 9.34 6.74 20.41
Price to Earnings (P/E)
12.76 13.00 10.99 12.04 18.63 22.22 13.24 17.95 36.37 23.20 65.25
Dividend Yield
1.64% 1.21% 1.60% 2.50% 1.59% 0.85% 1.36% 1.14% 0.75% 0.95% 0.27%
Earnings Yield
7.83% 7.69% 9.10% 8.30% 5.37% 4.50% 7.55% 5.57% 2.75% 4.31% 1.53%
Enterprise Value to Invested Capital (EV/IC)
2.72 5.51 6.19 7.16 10.13 17.01 8.42 10.23 18.03 15.39 44.44
Enterprise Value to Revenue (EV/Rev)
1.55 2.32 2.12 2.61 4.06 5.87 3.60 4.63 9.28 6.64 20.33
Enterprise Value to EBITDA (EV/EBITDA)
7.29 8.69 6.72 9.16 14.35 18.35 11.23 14.80 29.31 19.30 54.25
Enterprise Value to EBIT (EV/EBIT)
9.50 10.28 7.44 10.32 15.85 19.64 11.95 15.79 31.73 20.55 57.15
Enterprise Value to NOPAT (EV/NOPAT)
8.92 10.45 9.67 11.43 17.45 21.42 13.01 17.65 36.96 23.07 65.49
Enterprise Value to Operating Cash Flow (EV/OCF)
7.04 9.18 8.83 7.95 19.19 23.93 20.03 15.57 29.74 19.83 80.62
Enterprise Value to Free Cash Flow (EV/FCFF)
8.06 10.65 11.62 10.21 22.24 28.70 25.39 19.87 35.00 24.36 104.03
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.71 0.39 0.37 0.95 1.12 0.83 0.80 0.61 0.58 0.45 0.30
Long-Term Debt to Equity
0.55 0.26 0.27 0.81 0.96 0.83 0.80 0.61 0.52 0.38 0.30
Financial Leverage
-0.41 -0.49 -0.47 -0.35 -0.24 -0.19 0.01 0.05 -0.07 -0.15 -0.17
Leverage Ratio
1.89 1.86 1.81 2.17 2.68 2.72 2.69 2.48 2.24 2.18 2.01
Compound Leverage Factor
1.89 1.86 1.81 2.17 2.68 2.72 2.69 2.48 2.24 2.18 2.01
Debt to Total Capital
41.48% 27.82% 26.86% 48.73% 52.85% 45.35% 44.36% 37.90% 36.85% 31.26% 23.05%
Short-Term Debt to Total Capital
9.09% 9.38% 6.78% 7.24% 7.64% 0.10% 0.07% 0.06% 3.73% 5.26% 0.03%
Long-Term Debt to Total Capital
32.40% 18.44% 20.08% 41.49% 45.21% 45.25% 44.30% 37.84% 33.12% 26.00% 23.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.99% 1.75% 0.87% 0.54% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
56.53% 70.42% 72.27% 50.73% 47.05% 54.65% 55.64% 62.10% 63.15% 68.74% 76.95%
Debt to EBITDA
3.46 1.26 0.69 1.63 2.04 1.07 0.91 0.92 1.06 0.71 0.43
Net Debt to EBITDA
-2.20 -1.68 -0.80 -0.43 -0.41 -0.21 0.20 -0.06 -0.18 -0.30 -0.21
Long-Term Debt to EBITDA
2.70 0.83 0.52 1.39 1.75 1.07 0.90 0.92 0.95 0.59 0.43
Debt to NOPAT
4.23 1.51 1.00 2.03 2.49 1.25 1.05 1.10 1.33 0.85 0.52
Net Debt to NOPAT
-2.69 -2.02 -1.15 -0.54 -0.49 -0.24 0.23 -0.07 -0.23 -0.36 -0.26
Long-Term Debt to NOPAT
3.30 1.00 0.74 1.73 2.13 1.25 1.05 1.10 1.20 0.70 0.52
Altman Z-Score
3.09 5.07 5.89 5.43 5.70 9.02 7.39 8.64 12.15 10.63 30.44
Noncontrolling Interest Sharing Ratio
3.93% 2.88% 1.83% 1.13% 0.61% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.81 3.10 2.90 3.61 3.43 3.30 2.69 3.16 2.97 2.21 2.63
Quick Ratio
3.35 2.62 2.26 2.90 2.79 2.48 1.75 1.95 1.93 1.49 1.84
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,132 1,749 2,020 2,472 1,835 2,991 2,445 4,059 3,953 5,026 4,539
Operating Cash Flow to CapEx
738.60% 1,299.76% 971.13% 1,046.49% 1,046.28% 1,027.84% 567.67% 1,032.55% 1,172.83% 813.14% 606.13%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.54 0.66 0.90 0.79 0.76 0.96 1.04 0.97 0.79 0.92 1.04
Accounts Receivable Turnover
5.00 5.46 5.75 5.32 5.65 5.71 4.69 4.88 5.58 6.25 5.33
Inventory Turnover
3.41 4.00 3.80 3.10 3.16 3.41 2.81 2.20 1.74 2.22 2.68
Fixed Asset Turnover
9.34 12.09 13.95 0.00 0.00 0.00 0.00 9.95 7.43 8.04 8.63
Accounts Payable Turnover
10.08 10.85 12.12 11.93 11.22 11.00 10.16 13.03 14.48 12.88 10.67
Days Sales Outstanding (DSO)
73.04 66.85 63.44 68.67 64.55 63.93 77.76 74.74 65.41 58.38 68.48
Days Inventory Outstanding (DIO)
106.99 91.24 95.98 117.75 115.49 107.09 129.84 166.07 209.96 164.54 136.14
Days Payable Outstanding (DPO)
36.22 33.64 30.12 30.59 32.53 33.18 35.91 28.02 25.21 28.33 34.20
Cash Conversion Cycle (CCC)
143.81 124.45 129.30 155.83 147.51 137.84 171.68 212.78 250.17 194.59 170.42
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,350 3,383 3,791 3,527 4,030 5,047 7,375 7,885 7,675 7,955 10,626
Invested Capital Turnover
1.73 2.38 3.09 2.64 2.66 3.22 2.77 2.28 1.92 2.36 2.50
Increase / (Decrease) in Invested Capital
-109 34 407 -264 503 1,017 2,328 510 -210 281 2,671
Enterprise Value (EV)
9,122 18,631 23,463 25,242 40,807 85,847 62,081 80,661 138,355 122,424 472,234
Market Capitalization
11,667 22,065 26,174 26,389 41,949 86,827 60,984 80,987 139,220 124,330 474,079
Book Value per Share
$36.93 $42.26 $39.63 $31.17 $35.63 $42.26 $45.26 $61.11 $65.32 $7.71 $9.97
Tangible Book Value per Share
$24.71 $31.12 $28.65 $19.83 $24.25 $30.88 $33.60 $47.78 $51.82 $6.30 $8.46
Total Capital
10,428 9,681 8,997 9,213 10,994 11,029 11,284 13,222 13,523 14,346 16,205
Total Debt
4,326 2,693 2,417 4,490 5,811 5,002 5,006 5,012 4,983 4,485 3,735
Total Long-Term Debt
3,378 1,785 1,807 3,823 4,971 4,990 4,998 5,003 4,479 3,730 3,730
Net Debt
-2,752 -3,604 -2,789 -1,196 -1,153 -980 1,097 -326 -865 -1,906 -1,845
Capital Expenditures (CapEx)
175 156 273 303 203 349 546 502 397 759 966
Debt-free, Cash-free Net Working Capital (DFCFNWC)
915 1,060 1,660 1,425 1,821 2,407 4,070 3,715 3,202 2,312 4,098
Debt-free Net Working Capital (DFNWC)
7,743 7,101 6,610 6,856 8,531 8,136 7,728 9,052 9,050 8,703 9,678
Net Working Capital (NWC)
6,795 6,192 6,000 6,189 7,691 8,125 7,720 9,043 8,545 7,949 9,673
Net Nonoperating Expense (NNE)
109 85 46 16 86 99 167 58 -85 -51 -55
Net Nonoperating Obligations (NNO)
-2,752 -3,604 -2,789 -1,196 -1,153 -980 1,097 -326 -865 -1,906 -1,845
Total Depreciation and Amortization (D&A)
291 332 341 309 269 307 334 342 360 386 442
Debt-free, Cash-free Net Working Capital to Revenue
15.54% 13.22% 14.99% 14.76% 18.13% 16.46% 23.63% 21.31% 21.48% 12.54% 17.64%
Debt-free Net Working Capital to Revenue
131.55% 88.61% 59.67% 71.02% 84.93% 55.63% 44.86% 51.94% 60.71% 47.21% 41.65%
Net Working Capital to Revenue
115.45% 77.27% 54.16% 64.11% 76.57% 55.55% 44.82% 51.89% 57.33% 43.12% 41.64%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$5.75 $10.47 $14.73 $14.37 $15.55 $27.22 $32.92 $33.30 $29.13 $4.17 $5.79
Adjusted Weighted Average Basic Shares Outstanding
158.92M 162.22M 161.64M 152.48M 144.81M 143.61M 139.90M 135.47M 131.41M 1.29B 1.26B
Adjusted Diluted Earnings per Share
$5.22 $9.24 $13.17 $13.70 $15.10 $26.90 $32.75 $33.21 $29.00 $4.15 $5.76
Adjusted Weighted Average Diluted Shares Outstanding
175.16M 183.77M 180.78M 159.92M 149.09M 145.32M 140.63M 135.83M 132.00M 1.29B 1.26B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
160.26M 162.45M 157.58M 144.53M 145.63M 141.95M 136.99M 132.51M 129.88M 1.27B 1.25B
Normalized Net Operating Profit after Tax (NOPAT)
1,023 1,783 2,427 2,208 2,338 4,008 4,773 4,606 3,743 5,307 7,210
Normalized NOPAT Margin
17.38% 22.24% 21.91% 22.87% 23.28% 27.40% 27.70% 26.43% 25.11% 28.79% 31.04%
Pre Tax Income Margin
16.31% 22.61% 28.45% 25.34% 25.64% 29.88% 30.15% 29.32% 29.25% 32.32% 35.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
20.83% 14.34% 12.92% 30.95% 29.17% 18.60% 17.70% 20.13% 26.62% 21.45% 17.49%
Augmented Payout Ratio
38.16% 62.15% 124.37% 203.47% 90.00% 87.62% 101.64% 64.84% 100.89% 85.32% 70.50%

Quarterly Metrics And Ratios for Lam Research

This table displays calculated financial ratios and metrics derived from Lam Research's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/24/2023 3/31/2024 6/30/2024 9/29/2024 12/29/2024 3/30/2025 6/29/2025 9/28/2025 12/28/2025 3/29/2026 6/28/2026
DEI Shares Outstanding
- - - - - - - - - 1,248,771,000.00 1,250,571,000.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 1,248,771,000.00 1,250,571,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 1.46 1.82
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-28.79% -1.96% 20.71% 19.70% 16.44% 24.43% 33.58% 27.74% 22.14% 23.76% 29.99%
EBITDA Growth
-32.20% 14.80% 30.37% 24.41% 22.61% 38.12% 51.07% 41.21% 34.35% 30.22% 42.47%
EBIT Growth
-34.20% 16.43% 33.67% 26.19% 24.02% 40.57% 54.11% 43.64% 36.23% 30.90% 43.63%
NOPAT Growth
-37.86% 14.33% 25.38% 23.20% 26.97% 44.80% 69.07% 41.52% 33.32% 37.36% 33.07%
Net Income Growth
-35.02% 18.65% 27.13% 25.81% 24.81% 37.78% 68.59% 40.51% 33.83% 37.18% 32.39%
EPS Growth
-35.02% 22.13% 28.81% 25.81% 27.78% 41.10% 71.79% 44.19% 36.96% 40.78% 35.07%
Operating Cash Flow Growth
27.51% -19.79% -23.18% 64.90% -48.97% -5.50% 196.16% 13.42% 99.48% -12.78% -42.95%
Free Cash Flow Firm Growth
268.53% 354.85% 323.80% 97.59% -66.00% -89.88% 16.39% -39.91% 100.61% 491.78% -130.70%
Invested Capital Growth
-10.63% -5.89% -2.66% -6.18% 7.36% 16.52% 3.66% 8.06% 3.99% 11.98% 33.57%
Revenue Q/Q Growth
7.93% 0.94% 2.05% 7.66% 4.99% 7.86% 9.56% 2.95% 0.39% 9.29% 15.08%
EBITDA Q/Q Growth
5.54% 0.43% 5.04% 11.74% 4.02% 13.14% 14.89% 4.44% -1.03% 9.65% 25.70%
EBIT Q/Q Growth
5.99% 0.56% 5.60% 12.12% 4.16% 13.99% 15.76% 4.51% -1.21% 9.53% 27.02%
NOPAT Q/Q Growth
4.85% 0.63% 6.61% 9.52% 8.06% 14.76% 24.49% -8.33% 1.80% 18.24% 20.59%
Net Income Q/Q Growth
7.54% 1.21% 5.64% 9.43% 6.68% 11.73% 29.27% -8.80% 1.62% 14.52% 24.75%
EPS Q/Q Growth
7.54% 1.66% 5.99% 9.43% 6.98% 11.96% 30.10% -7.46% 1.61% 15.08% 24.83%
Operating Cash Flow Q/Q Growth
52.85% -4.75% -37.72% 81.87% -52.70% 76.38% 95.18% -30.35% -16.80% -22.88% 27.67%
Free Cash Flow Firm Q/Q Growth
129.07% -23.81% -13.48% 30.84% -60.58% -77.33% 895.44% -32.44% 31.59% -33.13% -151.64%
Invested Capital Q/Q Growth
-3.89% -3.10% 4.66% -3.74% 9.97% 5.17% -6.90% 0.35% 5.83% 13.25% 11.06%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
46.76% 47.46% 47.53% 48.05% 47.37% 49.02% 50.08% 50.43% 49.60% 49.83% 51.75%
EBITDA Margin
31.34% 31.19% 32.10% 33.32% 33.01% 34.62% 36.30% 36.83% 36.31% 36.43% 39.79%
Operating Margin
28.13% 27.87% 29.10% 30.33% 30.48% 33.09% 33.67% 34.35% 33.87% 35.04% 37.39%
EBIT Margin
28.92% 28.82% 29.82% 31.05% 30.81% 32.56% 34.40% 34.92% 34.36% 34.44% 38.01%
Profit (Net Income) Margin
25.39% 25.46% 26.35% 26.79% 27.22% 28.19% 33.26% 29.46% 29.82% 31.25% 33.88%
Tax Burden Percent
87.78% 88.35% 88.39% 86.26% 88.34% 86.59% 96.69% 84.37% 86.79% 90.75% 89.13%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
12.22% 11.65% 11.61% 13.74% 11.66% 13.41% 3.31% 15.63% 13.21% 9.25% 10.87%
Return on Invested Capital (ROIC)
44.09% 46.36% 49.28% 53.45% 55.63% 61.84% 76.79% 73.89% 72.93% 76.13% 83.33%
ROIC Less NNEP Spread (ROIC-NNEP)
33.40% 41.47% 45.15% 49.32% 53.74% 64.46% 74.15% 72.35% 71.00% 79.38% 81.35%
Return on Net Nonoperating Assets (RNNOA)
-0.99% -3.29% -3.21% -3.75% -4.22% -6.09% -11.17% -12.76% -8.92% -7.83% -13.66%
Return on Equity (ROE)
43.10% 43.07% 46.07% 49.70% 51.41% 55.75% 65.63% 61.12% 64.02% 68.30% 69.67%
Cash Return on Invested Capital (CROIC)
53.94% 52.90% 50.81% 58.12% 46.41% 42.90% 64.31% 67.19% 70.33% 62.19% 48.86%
Operating Return on Assets (OROA)
21.80% 21.87% 23.69% 25.43% 25.86% 29.17% 31.64% 33.02% 34.27% 36.64% 39.36%
Return on Assets (ROA)
19.14% 19.33% 20.94% 21.94% 22.84% 25.26% 30.59% 27.86% 29.74% 33.25% 35.08%
Return on Common Equity (ROCE)
43.10% 43.07% 46.07% 49.70% 51.41% 55.75% 65.63% 61.12% 64.02% 68.30% 69.67%
Return on Equity Simple (ROE_SIMPLE)
42.06% 45.00% 0.00% 47.89% 48.75% 48.98% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
928 934 996 1,090 1,178 1,352 1,683 1,543 1,571 1,858 2,240
NOPAT Margin
24.69% 24.62% 25.72% 26.16% 26.93% 28.65% 32.55% 28.99% 29.39% 31.80% 33.32%
Net Nonoperating Expense Percent (NNEP)
10.69% 4.89% 4.13% 4.13% 1.88% -2.62% 2.64% 1.54% 1.93% -3.25% 1.98%
Return On Investment Capital (ROIC_SIMPLE)
7.03% - - - 8.55% 9.66% 11.73% 10.52% 10.74% 12.97% 13.82%
Cost of Revenue to Revenue
53.24% 52.54% 52.47% 51.95% 52.63% 50.98% 49.92% 49.57% 50.40% 50.17% 48.25%
SG&A Expenses to Revenue
6.09% 5.69% 5.59% 5.83% 5.58% 4.79% 5.19% 5.25% 5.01% 4.80% 4.80%
R&D to Revenue
12.50% 13.50% 12.86% 11.88% 11.31% 11.14% 11.22% 10.83% 10.73% 9.98% 9.56%
Operating Expenses to Revenue
18.63% 19.60% 18.43% 17.72% 16.89% 15.93% 16.41% 16.07% 15.73% 14.78% 14.36%
Earnings before Interest and Taxes (EBIT)
1,087 1,093 1,154 1,294 1,348 1,537 1,779 1,859 1,837 2,012 2,555
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,178 1,183 1,243 1,389 1,444 1,634 1,877 1,961 1,941 2,128 2,675
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
12.38 15.85 16.30 12.68 10.72 9.80 12.61 15.93 22.05 24.94 38.01
Price to Tangible Book Value (P/TBV)
15.79 20.33 20.55 16.00 13.40 12.08 15.44 19.41 27.01 30.34 44.83
Price to Revenue (P/Rev)
7.11 8.93 9.34 6.89 5.83 5.44 6.74 8.29 10.88 12.18 20.41
Price to Earnings (P/E)
29.43 35.22 36.37 26.48 22.00 20.01 23.20 27.95 36.00 39.36 65.25
Dividend Yield
0.96% 0.80% 0.75% 1.00% 1.17% 1.23% 0.95% 0.74% 0.68% 0.48% 0.27%
Earnings Yield
3.40% 2.84% 2.75% 3.78% 4.55% 5.00% 4.31% 3.58% 2.78% 2.54% 1.53%
Enterprise Value to Invested Capital (EV/IC)
13.36 17.24 18.03 14.39 11.54 10.80 15.39 20.07 26.27 27.49 44.44
Enterprise Value to Revenue (EV/Rev)
7.06 8.88 9.28 6.82 5.78 5.38 6.64 8.18 10.80 12.13 20.33
Enterprise Value to EBITDA (EV/EBITDA)
23.63 28.54 29.31 21.30 17.83 16.16 19.30 23.16 29.94 33.26 54.25
Enterprise Value to EBIT (EV/EBIT)
25.82 31.07 31.73 22.97 19.17 17.29 20.55 24.56 31.66 35.13 57.15
Enterprise Value to NOPAT (EV/NOPAT)
29.52 35.71 36.96 26.93 22.33 19.98 23.07 27.82 36.08 39.51 65.49
Enterprise Value to Operating Cash Flow (EV/OCF)
19.24 25.74 29.74 20.18 20.57 20.58 19.83 25.10 31.17 37.81 80.62
Enterprise Value to Free Cash Flow (EV/FCFF)
23.38 31.61 35.00 23.98 25.74 27.08 24.36 31.02 38.08 46.70 104.03
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.61 0.62 0.58 0.59 0.57 0.47 0.45 0.44 0.44 0.35 0.30
Long-Term Debt to Equity
0.61 0.56 0.52 0.53 0.51 0.39 0.38 0.37 0.37 0.35 0.30
Financial Leverage
-0.03 -0.08 -0.07 -0.08 -0.08 -0.09 -0.15 -0.18 -0.13 -0.10 -0.17
Leverage Ratio
2.30 2.28 2.24 2.30 2.27 2.18 2.18 2.22 2.18 2.03 2.01
Compound Leverage Factor
2.30 2.28 2.24 2.30 2.27 2.18 2.18 2.22 2.18 2.03 2.01
Debt to Total Capital
37.74% 38.32% 36.85% 37.04% 36.13% 32.04% 31.26% 30.55% 30.65% 26.08% 23.05%
Short-Term Debt to Total Capital
0.03% 3.88% 3.73% 3.75% 3.66% 5.39% 5.26% 5.14% 5.15% 0.03% 0.03%
Long-Term Debt to Total Capital
37.71% 34.43% 33.12% 33.29% 32.47% 26.65% 26.00% 25.41% 25.50% 26.05% 23.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
62.26% 61.68% 63.15% 62.96% 63.87% 67.96% 68.74% 69.45% 69.35% 73.92% 76.95%
Debt to EBITDA
1.17 1.12 1.06 1.00 0.95 0.79 0.71 0.65 0.60 0.47 0.43
Net Debt to EBITDA
-0.15 -0.16 -0.18 -0.22 -0.13 -0.17 -0.30 -0.32 -0.23 -0.13 -0.21
Long-Term Debt to EBITDA
1.16 1.01 0.95 0.90 0.85 0.65 0.59 0.54 0.50 0.47 0.43
Debt to NOPAT
1.46 1.41 1.33 1.26 1.19 0.97 0.85 0.78 0.73 0.56 0.52
Net Debt to NOPAT
-0.19 -0.19 -0.23 -0.27 -0.16 -0.21 -0.36 -0.38 -0.28 -0.15 -0.26
Long-Term Debt to NOPAT
1.45 1.26 1.20 1.13 1.07 0.81 0.70 0.65 0.61 0.56 0.52
Altman Z-Score
9.04 10.78 11.58 9.18 8.55 8.87 9.98 11.87 15.68 19.57 29.64
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.06 2.82 2.97 2.53 2.54 2.45 2.21 2.21 2.26 2.54 2.63
Quick Ratio
1.95 1.78 1.93 1.69 1.68 1.58 1.49 1.54 1.56 1.69 1.84
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,829 1,393 1,205 1,577 622 141 1,403 948 1,247 834 -431
Operating Cash Flow to CapEx
1,261.18% 1,336.02% 856.03% 1,418.30% 393.92% 454.31% 1,483.35% 960.97% 567.33% 344.21% 771.83%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.75 0.76 0.79 0.82 0.84 0.90 0.92 0.95 1.00 1.06 1.04
Accounts Receivable Turnover
4.22 5.21 5.58 5.42 5.39 6.31 6.25 5.96 6.05 5.89 5.33
Inventory Turnover
1.70 1.64 1.74 1.83 1.93 2.03 2.22 2.39 2.46 2.56 2.68
Fixed Asset Turnover
0.00 0.00 7.43 7.21 7.27 7.53 8.04 8.29 8.18 8.30 8.63
Accounts Payable Turnover
11.05 13.36 14.48 13.29 12.85 12.86 12.88 12.67 11.16 11.27 10.67
Days Sales Outstanding (DSO)
86.39 70.04 65.41 67.28 67.69 57.85 58.38 61.20 60.33 61.96 68.48
Days Inventory Outstanding (DIO)
215.28 221.91 209.96 199.59 188.85 180.04 164.54 152.63 148.46 142.41 136.14
Days Payable Outstanding (DPO)
33.03 27.33 25.21 27.46 28.41 28.38 28.33 28.81 32.70 32.39 34.20
Cash Conversion Cycle (CCC)
268.65 264.62 250.17 239.42 228.13 209.51 194.59 185.02 176.09 171.98 170.42
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
7,568 7,333 7,675 7,388 8,125 8,545 7,955 7,984 8,449 9,568 10,626
Invested Capital Turnover
1.79 1.88 1.92 2.04 2.07 2.16 2.36 2.55 2.48 2.39 2.50
Increase / (Decrease) in Invested Capital
-900 -459 -210 -487 557 1,211 281 595 324 1,024 2,671
Enterprise Value (EV)
101,107 126,449 138,355 106,339 93,760 92,240 122,424 160,208 221,965 262,986 472,234
Market Capitalization
101,761 127,138 139,220 107,423 94,443 93,207 124,330 162,417 223,661 264,003 474,079
Book Value per Share
$62.39 $61.19 $65.32 $65.23 $6.85 $7.41 $7.71 $8.05 $8.08 $8.48 $9.97
Tangible Book Value per Share
$48.90 $47.70 $51.82 $51.69 $5.48 $6.01 $6.30 $6.61 $6.59 $6.97 $8.46
Total Capital
13,206 13,006 13,523 13,456 13,790 13,995 14,346 14,677 14,629 14,319 16,205
Total Debt
4,984 4,983 4,983 4,984 4,982 4,484 4,485 4,484 4,484 3,734 3,735
Total Long-Term Debt
4,980 4,478 4,479 4,479 4,478 3,730 3,730 3,730 3,730 3,730 3,730
Net Debt
-654 -689 -865 -1,084 -683 -966 -1,906 -2,209 -1,697 -1,016 -1,845
Capital Expenditures (CapEx)
115 104 101 111 188 288 172 185 261 332 189
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3,148 2,891 3,202 2,587 3,101 3,274 2,312 2,160 2,378 3,308 4,098
Debt-free Net Working Capital (DFNWC)
8,786 8,563 9,050 8,654 8,767 8,725 8,703 8,853 8,559 8,059 9,678
Net Working Capital (NWC)
8,782 8,058 8,545 8,150 8,263 7,970 7,949 8,099 7,805 8,055 9,673
Net Nonoperating Expense (NNE)
-26 -32 -25 -26 -13 22 -37 -25 -23 32 -37
Net Nonoperating Obligations (NNO)
-654 -689 -865 -1,084 -683 -966 -1,906 -2,209 -1,697 -1,016 -1,845
Total Depreciation and Amortization (D&A)
91 90 88 94 96 97 98 102 104 116 120
Debt-free, Cash-free Net Working Capital to Revenue
21.99% 20.30% 21.48% 16.59% 19.13% 19.11% 12.54% 11.03% 11.57% 15.26% 17.64%
Debt-free Net Working Capital to Revenue
61.37% 60.13% 60.71% 55.51% 54.09% 50.92% 47.21% 45.19% 41.63% 37.17% 41.65%
Net Working Capital to Revenue
61.34% 56.59% 57.33% 52.27% 50.97% 46.51% 43.12% 41.34% 37.96% 37.15% 41.64%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.73 $7.38 $7.81 $0.86 $0.93 $1.04 $1.34 $1.24 $1.27 $1.46 $1.81
Adjusted Weighted Average Basic Shares Outstanding
1.32B 130.84M 131.41M 1.30B 1.29B 1.28B 1.29B 1.26B 1.25B 1.25B 1.26B
Adjusted Diluted Earnings per Share
$0.72 $7.34 $7.78 $0.86 $0.92 $1.03 $1.34 $1.24 $1.26 $1.45 $1.81
Adjusted Weighted Average Diluted Shares Outstanding
1.32B 131.52M 132.00M 1.30B 1.29B 1.29B 1.29B 1.27B 1.26B 1.26B 1.26B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.34 $0.00 $0.00 $0.00 $1.81
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.31B 130.74M 129.88M 1.29B 1.28B 1.28B 1.27B 1.26B 1.25B 1.25B 1.25B
Normalized Net Operating Profit after Tax (NOPAT)
928 947 996 1,090 1,178 1,352 1,683 1,543 1,571 1,858 2,240
Normalized NOPAT Margin
24.69% 24.97% 25.72% 26.16% 26.93% 28.65% 32.55% 28.99% 29.39% 31.80% 33.32%
Pre Tax Income Margin
28.92% 28.82% 29.82% 31.05% 30.81% 32.56% 34.40% 34.92% 34.36% 34.44% 38.01%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
27.79% 27.42% 26.62% 25.87% 25.22% 23.95% 21.45% 20.32% 19.48% 18.49% 17.49%
Augmented Payout Ratio
112.80% 119.89% 100.89% 99.74% 96.23% 77.70% 85.32% 78.85% 86.59% 91.49% 70.50%

Financials Breakdown Chart

Key Financial Trends

Lam Research (NASDAQ: LRCX) continued its strong recovery in fiscal 2026. Fourth-quarter revenue increased to $6.72 billion, up from $5.84 billion in the third quarter and approximately 30% above the $5.17 billion reported in Q4 2025. The company’s growth has accelerated from the weaker revenue levels seen during fiscal 2024, when quarterly revenue was generally below $4.4 billion.

Profitability also improved meaningfully. Fourth-quarter gross profit rose to $3.48 billion, producing a gross margin of approximately 51.7%, compared with 49.8% in Q3. Operating income increased to $2.51 billion, while net income reached $2.28 billion, or $1.81 per diluted share. Net income was up approximately 32% from Q4 2025, and the operating margin expanded to about 37.4% from 35.0% in the prior quarter.

  • Revenue momentum is improving: Quarterly revenue advanced from $3.21 billion in Q4 2023 to $6.72 billion in Q4 2026, indicating a substantial recovery in demand for Lam Research’s semiconductor manufacturing equipment.
  • Margins are expanding: Gross margin improved from approximately 47.5% in Q4 2025 to 51.7% in Q4 2026, while operating margin rose from 33.7% to 37.4% over the same period.
  • Earnings growth has been strong: Quarterly net income increased from $802.5 million in Q4 2023 to $2.28 billion in Q4 2026. Diluted EPS also rose from $1.34 in Q4 2025 to $1.81 in the latest quarter.
  • Research and development spending is supporting growth: R&D expense reached $642.9 million in Q4 2026, up from $580.2 million in Q4 2025. The spending represents continued investment in products and technologies that could support future semiconductor equipment demand.
  • Operating cash flow remains substantial: Lam Research generated $1.46 billion of operating cash flow in Q4 2026 and more than $5.8 billion during fiscal 2026 based on the quarterly figures provided.
  • Capital returns remain significant: The company repurchased approximately $3.86 billion of stock across fiscal 2026 and paid roughly $1.30 billion in dividends. These actions can support per-share earnings and shareholder returns when the business continues generating strong cash flow.
  • Debt has become more manageable: Short-term debt declined from $754 million in Q1 2026 to just $4 million in Q3, while long-term debt remained broadly stable near $3.7 billion. Total liabilities also declined from $11.7 billion in Q1 to $10.2 billion in Q3.
  • Working-capital movements are volatile: Changes in operating assets and liabilities reduced Q4 operating cash flow by approximately $1.04 billion, following an $894 million reduction in Q3. This may reflect investment in receivables, inventory or other operating assets rather than a deterioration in reported earnings, but it warrants monitoring.
  • Receivables remain elevated: Accounts receivable increased from $2.52 billion at the end of fiscal 2024 to $4.13 billion in Q3 2026. The increase is consistent with higher sales, but investors should watch collections and customer payment trends.
  • Cash balances have declined during fiscal 2026: Cash and equivalents fell from $6.69 billion at the end of Q1 2026 to $4.75 billion at the end of Q3, primarily as the company funded buybacks, dividends, debt repayment and capital expenditures. Q4 cash flow improved by $831 million, but the company’s cash cushion remains below its fiscal-year starting level.

Lam Research’s balance sheet remains supported by more than $20 billion of total assets and approximately $10.6 billion of common equity as of Q3 2026. Net property, plant and equipment has increased from $2.15 billion at the end of fiscal 2024 to $2.85 billion, suggesting continued investment in operating capacity. However, total inventory remains substantial at approximately $4.0 billion, and the recent working-capital cash outflows indicate that growth is requiring additional funding.

Overall, the financial statements show a company benefiting from powerful revenue growth, improving margins and strong profitability. The primary risks are cash conversion, elevated receivables, semiconductor-cycle volatility and the large amount of capital being returned to shareholders. For retail investors, the latest figures present a favorable operating trend, although sustaining growth while maintaining cash generation will be important for the stock’s longer-term performance.

08/18/26 06:03 AM ETAI Generated. May Contain Errors.

Lam Research Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lam Research's financial year ends in June. Their financial year 2026 ended on June 28, 2026.

Lam Research's net income appears to be on an upward trend, with a most recent value of $7.27 billion in 2026, rising from $914.05 million in 2016. The previous period was $5.36 billion in 2025. See Lam Research's forecast for analyst expectations on what's next for the company.

Lam Research's total operating income in 2026 was $8.20 billion, based on the following breakdown:
  • Total Gross Profit: $11.73 billion
  • Total Operating Expenses: $3.53 billion

Over the last 10 years, Lam Research's total revenue changed from $5.89 billion in 2016 to $23.23 billion in 2026, a change of 294.7%.

Lam Research's total liabilities were at $11.06 billion at the end of 2026, a 3.7% decrease from 2025, and a 79.5% increase since 2016.

In the past 10 years, Lam Research's cash and equivalents has ranged from $2.38 billion in 2017 to $6.39 billion in 2025, and is currently $5.58 billion as of their latest financial filing in 2026.

Over the last 10 years, Lam Research's book value per share changed from 36.93 in 2016 to 9.97 in 2026, a change of -73.0%.



Financial statements for NASDAQ:LRCX last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners